Go to PegaPoll
PEGAPOLL · NEWS

Common osteoporosis drug prevented spinal mineral damage in zebrafish study

ScienceDaily · 2026-11-15
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.

An existing osteoporosis medicine has stopped abnormal mineral from forming in zebrafish spines, a finding that researchers hope could eventually inform treatments for chronic neck and back pain. In the fish, that mineralisation hardens tissues that should stay flexible and can fuse neighbouring vertebrae. The work, from the Universities of Edinburgh and Bristol, also maps shifts in gene activity and metabolism that appear to drive the damage, and it has not yet been confirmed in people.

A common source of back pain is wear of the intervertebral discs that cushion the vertebrae, distribute load and allow comfortable movement. As those discs fail — intervertebral disc degeneration, or IVDD — pain, stiffness and lost mobility can follow. No drug currently stops or reverses that process; surgery is the only established long-term option in some severe cases, despite the condition’s wide human and economic cost.

Genetics is known to affect risk. Variations linked to collagen IX, a protein that supports the fibre network holding discs together, have repeatedly been tied to disc trouble earlier in life. Scientists studied zebrafish bred without a working copy of that gene. As the animals aged, their spines resembled human degenerative disease: mineral collected where it does not belong, and vertebrae fused. The damage started earlier still, when a supporting layer from spinal development began to break down, suggesting that loss of this framework sets up later hardening.

Molecular analysis found disrupted fat metabolism, altered mTOR signalling (which governs cell growth, metabolism and nutrient responses), and changes in phosphate regulation and vitamin A signalling. Phosphate is needed to build bone and teeth, but its misplacement is part of the harmful mineral buildup the osteoporosis drug blocked. The study argues that zebrafish can both expose causes of spinal disease and be used to test therapies, including medicines already prescribed for other conditions, that might slow degeneration.

Continue in the app — vote & join in ➔
Source: ScienceDaily · via ahirlevel.hu

Related news